VJHemOnc is committed to improving our service to you

ICML 2019 | AATT study final results: allo or auto transplant for consolidation in T-cell lymphoma?

VJHemOnc is committed to improving our service to you

Olivier Tournilhac

Olivier Tournilhac, MD, PhD, Clermont-Ferrand University Hospital, Clermont-Ferrand, France, discusses the Autologous or Allogeneic Transplantation in T-cell lymphoma (AATT) study. This interview took place at the 15th International Conference on Malignant Lymphoma (ICML), in Lugano, Switzerland.

Screen reader support enabled.

Olivier Tournilhac, MD, PhD, Clermont-Ferrand University Hospital, Clermont-Ferrand, France, discusses the Autologous or Allogeneic Transplantation in T-cell lymphoma (AATT) study. This interview took place at the 15th International Conference on Malignant Lymphoma (ICML), in Lugano, Switzerland.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter